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Abstract.  We have prepared a monoclonal antibody, 
AEll,  that recognizes specifically a  195-kD protein (pI 
5.4) of human keratinocytes.  This antigen constitutes 
,o0.01-0.1%  of total protein in keratinocytes of skin, 
esophagus, and cornea,  and is readily detectable in 
these cells by immunofluorescent staining and immu- 
noblotting.  However, it is barely detectable in MCF 
mammary carcinoma cells and HeLa cells, and is un- 
detectable in nonepithelial cell types. Results from 
serial extraction experiments have shown that this pro- 
tein exists in two distinct pools: a Tris-soluble,  and a 
Tris-insoluble but urea- or SDS-soluble one.  The dis- 
tribution of the  195-kD protein between these two 
pools appears to be differentiation-related,  since rela- 
tively undifferentiated cells selected by a low-calcium 
medium contain primarily the soluble form, while 
highly differentiated cells contain mainly the insoluble 
form.  Data from immunofluorescent staining and 
trypsin-sensitivity experiments suggest that the soluble 
form is cytoplasmic, whereas the insoluble form is 
submembranously located at the cell periphery of up- 
per, differentiated cells. The insoluble, cell peripheral 
form of the 195-kD antigen increases progressively 
during epidermal differentiation;  its insolubility ap- 
pears to be related to the formation of disulfide- 
bond(s).  These results indicate that the  195-kD pro- 
tein,  which has recently been suggested to be involved 
in cornified envelope formation (Simon, M., and H. 
Green,  1985, Cell, 36:827-834), undergoes significant 
changes in its solubility characteristics and intracellu- 
lar location during  keratinocyte maturation. 
UdPaNG terminal  differentiation,  epidermal cells un- 
ergo major biochemical changes.  The molecules 
that undergo such alterations can be divided into two 
broad categories according to their intracellular  location.  (a) 
Cytoplasmic proteins such as keratins.  Immunolocalization 
and cell fractionation experiments have established that basal 
cells of normal epidermis synthesize two major keratin poly- 
peptides,  a 50/50'-kD acidic keratin and a 58-kD basic kera- 
tin,  whereas cells of the suprabasal  layers possess an addi- 
tional 56.5-kD acidic and a 65-67-kD basic keratin (3, 5, 20, 
23, 26, 27, 30, 31, 33). (b) Cell peripheral proteins,  including 
involucrin  (1,  18), kerotolinin  (34), and several other high 
molecular weight proteins (21, 22). Serving as the substrates 
for the Ca++-dependent transglutaminase  (8, 28), these pro- 
teins are covalently cross-linked,  forming  a cornified enve- 
lope which is a submembranous structure characteristic  of 
the cornified cells (17, 24). 
In a  series of experiments  designed to generate mono- 
clonal  antibodies  to  the  keratinocyte  cell  surface and  its 
related  components, we fused the spleen cells from Balb/c 
mice previously immunized  with intact,  human epidermal 
keratinocytes  with X63.Ag8.653 mouse myeloma cells.  Su- 
pernatants  from  wells  containing  hybridoma  cells  were 
screened for their ability to stain the periphery of keratino- 
cytes in frozen sections of human epidermis by indirect  im- 
munofluorescent  staining.  We report here that the antibody 
secreted by one of these hybridoma lines,  AEll,  defines a 
195-kD keratinocyte component that undergoes novel differ- 
entiation-related  changes  in its  solubility property and its 
intracellular  location (from cytoplasmic  to peripheral). 
Materials and Methods 
Human Tissues 
Specimens of  human  tissues were obtained from autopsies performed within 
12-24 h after death. Human cornea and newborn foreskin were obtained 
from the Manhattan Eye, Ear, and Throat Hospital in New York, and from 
the nursery at the New York University Hospital, New York, respectively. 
Tissues were frozen in OCT-embedding medium, stored at -20°C, and sec° 
tioned within 2  wk. 
Cell Culture 
Human epidermal cells were grown from newborn foreskin using milo- 
mycin-treated 313 fibroblasts as a feeder layer (15, 16). Melanoma cell line 
RPMI-72 and cultured human endothelial cells were kindly supplied by Drs. 
Ruth Crowe and Daniel Rifkin of New York University. Neuroblastoma cell 
lines T17-SY5Y  were kindly supplied by Dr.  Douglas lshii of Columbia 
University, New York.  Epidermal cell "monolayer" were obtained by an 
overnight treatment of a  confluent epidermal culture with a  low-calcium 
(0.2 raM) medium (7). 
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The Journal of Cell Biology, Volume  103, July 1986 41-48  41 Figure 1. Immunoblot analysis of total proteins (50 Ixg) from vari- 
ous human cells using AEll antibody.  Lane 1, abdominal epider- 
mis.  Lane 2,  cultured newborn foreskin epidermal cells. Lane 3, 
esophageal epithelium. Lane 4, HeLa cells. Lane 5, mammary car- 
cinoma cells (MCF-7).  Lane 6,  cultured melanoma cells (RPMI- 
72).  Lane 7, cultured foreskin capillary endothelial cells (courtesy 
of R. Crowe and D. Rifldn). Lane 8, cultured neuroblastoma cells 
(CRL-1420).  Lane 9, dermal fibroblasts.  Lane 10, CRL-1420 pan- 
creatic carcinoma cells. Note that AEll antibody detects a  195-kD 
protein  in  the  epidermis,  cultured  epidermal  cells,  and  in  vivo 
esophageal epithelium, with little or no reaction in other cell types. 
Monoclonal Antibody Production 
Human  epidermal  cells  were  obtained  by  trypsinization  of  in  vivo 
epidermis,  suspended  in Dulbecco's modified Eagle's medium  (DMBM) 
supplemented with  10% fetal calf serum and  10% glycerol,  and stored in 
liquid nitrogen.  Approximately  106 thawed cells were washed and resus- 
pended in phosphate buffered saline (PBS), mixed with an equal volume of 
Freund's complete adjuvant, and injected subcutaneously into female Balb/c 
mice. Subsequent immunizations were given intraperitoneally at 2--4-wk in- 
tervals until the mouse sera gave positive immunofluorescent staining on fro- 
zen skin  sections at  1:100 dilution.  Mouse  spleen cells were  fused with 
X63.AgS.653 mouse myeloma cells in polyethylene glycol, and selected in 
hypoxanthine/aminopterin/thymidine  medium  (9).  The supernatants were 
screened  by  immunofluorescence  or  peroxidase-antiperoxidase  (PAP)  1 
staining of human skin sections (33). The hybridoma cells that gave periph- 
eral staining of epidermal cells were cloned three times by serial dilution. 
Sequential Extraction of  Proteins 
Tissues or cultured cells were first extracted at 4°C in a buffer containing 
50 mM Tris.HCl  (pH 7.4),  1 mM phenylmethyl sulfonylfluoride,  1 mM 
EGTA, 1 mM EDTA, 5 gg/ml antipain,  and 5 I.tg/ml pepstatin A (Buffer 
A, [33]), centrifuged at 15,000 g for 30 min. The pellet was then extracted 
with 1% Triton X-100 in Buffer A, and finally with either 2% SDS or 8 M 
urea in Buffer A. 
Total proteins were prepared by heating the cells in Buffer A containing 
2% SDS, with or without  1% 13-mercaptoethanol, at 95°C for 5 min. 
Gel Electrophoretic and Immunoblot Techniques 
Proteins were separated by SDS gel electrophoresis according to Laemmli 
using a  12.5% gel (acrylamide to bis-acrylamide  ratio:  120/1; [10]). Two- 
dimensional,  nonequilibrium  gel electrophoresis  was  performed  as  de- 
scribed  previously  (12). The separated  proteins  were electrophoretically 
transferred onto nitrocellulose paper and stained with monoclonal antibody, 
using the PAP method (29, 33). 
lmmunocytochemical Staining and Antibodies 
Unfixed,  frozen  tissue  sections  were  stained  by  the  indirect  immuno- 
fluoresence,  PAP, or avidin-biotin  complex techniques  (Vector Laborato- 
ries, Inc., Burlingame, CA). Other antibodies used include a supernatant from 
P3 (secretor) myeloma cells, a rabbit antikeratin antiserum (25, 26),  AE3 
1. Abbreviation used in this paper: PAP, peroxidase-antiperoxidase. 
Figure  2.  Identification  of the  AEll-antigen  in  cultured  human 
epidermal keratinocytes by two-dimensional immunoblotting. Total 
proteins (200 ttg) of  cultured human epidermal ceils were separated 
by  nonequilibrium pH-gradient  (NEpHG)  electrophoresis  in the 
first dimension,  and  SDS gel in the second dimension.  (a)  Fast 
green  staining  of protein  spots  transferred  electrophoretically to 
nitrocellulose paper.  Arrows in this gel and in b denote the single 
spot recognized by AEll antibody.  (b) The same blot as shown in 
a  was stained with AEll by the PAP technique.  Downward arrow 
on the right denotes  a  side lane of one-dimensional blotting  in- 
cluded to  facilitate the comparison of one- and two-dimensional 
results. In the side lane the additional AEll-reactive band (I) that 
is slightly below the major 195-kD band (o) is variable in intensity 
and is probably a  degradative product. 
monoclonal antikemtin antibody (33), a rabbit antidesmosomal antiserum 
from Dr. Malcolm Steinberg of Princoton University, Princeton,  NJ, (6), 
and a mouse polyclonal antiserum specific for a 195-kD protein from Drs. 
Marcia Simon and Howard Green of  Harvard Medical School, Boston, MA. 
(21). 
Results 
Antigenic Specificity of  AEll Antibody 
In the course of characterizing a number of monoclonal anti- 
bodies prepared against human epidermal keratinocytes, we 
found that one of  these antibodies, AEll, produced strong pe- 
ripheral staining in cells of the suprabasal layers of normal 
The Journal of Cell Biology, Volume 103, 1986  42 Figure 3. Immunohistochemical  staining of various human skin-related epithelial cells using AEll antibody. (a, c-e) By immunofluores- 
cence. (b) By the PAP technique. (a and b) Epidermis. Note the strong cell periphery staining of the upper cell layers. Arrows denote 
the epidermal-dermal junction. Arrowheads in b denote the superficial surface of stratum comeum. The immunofluorescent  staining of 
stratum corneum (a) may be nonspecific,  as no stratum corneum staining was produced by the more specific  PAP staining (b). (c) Epidermis 
at a higher magnification. Note  the punctate or granular AEll-staining pattern in some areas (arrows). (d) Sweat glands. Note the preferen- 
tial staining of upper cells in the ducts (arrows, epithelial-mesenchymal  junction) and the lack of AEll-stalning in the glandular portion 
(arrowheads). (e) Hair follicle. Note the positive staining of inner root sheath (IRS), and the weak or no staining of the outer root sheath 
(ORS). Hair cortex (HC) exhibits weak, possibly nonspeeific, staining. Bars, 20 gm. 
human epidermis, suggesting that the antigen defined by this 
antibody undergoes differentiation-related changes. Immu- 
noblotting experiments show that AEll recognizes a single 
195-kD  component in keratinocytes of normal abdominal 
epidermis  (Fig.  1,  lane  1),  cultured  newborn  foreskin 
epidermal cells (lane 2), and in vivo esophageal epithelium 
(lane 3).  This AEll-reactive,  195-kD antigen is barely de- 
tectable in MCF mammary carcinoma cells (lane 4)  and 
HeLa cervical carcinoma cells (lane 5; also data not shown); 
but is undetectable in melanoma cells (lane  6),  foreskin- 
derived capillary endothelial cells (lane 7), neuroblastoma 
cells (lane 8), skin fibroblasts (lane 9), or pancreatic carci- 
noma cells (lane 10). 
When total proteins of cultured human epidermal kera- 
tinocytes  were  separated  by  two-dimensional,  nonequi- 
librium gel electrophoresis, and immunoblotted, the AEll- 
antigen was detected as a single spot (pI ~,5.4; Fig. 2). This 
spot is at least partly proteinaceous in nature because it is 
protease-sensitive (see below) and can be labeled biosynthet- 
ically with [35S]methionine (data not shown). It was barely 
detectable by Coomassie Blue R-250 or Fast green staining 
when 200 ~tg of total proteins from cultured keratinocytes was 
loaded on a two-dimensional gel. This suggests it is a rela- 
tively minor component constituting <0.1%  of total cellular 
proteins.  Co-electrophoresis experiments have established 
that this same 195-kD, pI 5.4 spot exists in normal human 
epidermis (data not shown). 
Immunolocalization of the 195-kD Protein 
Immunohistochemical staining of various human cells and 
tissues shows that AEll decorates primarily the cell periphery 
of  upper cells in various stratified squamous epithelia includ- 
ing epidermis (Fig. 3, a  and b),  sweat gland ducts (Fig. 3 
d), hair follicle (Fig. 3 e), esophageal epithelium (Fig. 4 a), 
corneal epithelium (Fig. 4 b), exocervical epithelium (Fig. 
4  c),  and cultured human epidermal colonies (Fig.  5).  In 
most of  the above-mentioned AEll-positive cells, we also no- 
ticed a variable degree of cytoplasmic staining (see below). 
However, only extremely weak to negligible staining was ob- 
served in kidney (Fig. 4 d), liver (Fig. 4 e), and in various 
Ma and Sun 195-kD Protein and Keratinocyte Differentiation  43 Figure 4. AEll-immunofluorescent staining of various  human (nonepidermal)  epithelial  tissue.  (a) Esophageal epithelium.  Note the cell 
periphery staining of  upper layers. Arrows denote the epithelial-stromal junction, and * represents the lumen of  an esophageal duct coursing 
through the epithelium.  (b) Corneal epithelium.  BM, Bowman's membrane. (c) Exocervical epithelium.  Arrows point to epithelial-stromal 
junction.  (d) Liver.  (e) Kidney. Bar,  20 Ixm. 
Figure 5. Immunofluorescent staining of cultured human epidermal colonies with AEll antibody. (a) Top view. Human epidermal colonies 
were grown on glass coverslips,  fixed with methanol, and stained with AEll. Arrows denote the edge of the colony.  Note the uniform, 
The Jourua] of Cell Biology,  Volume 103, 1986  44 nonepithelial components (Figs.  3  and 4),  confirming the 
predominantly keratinocyte-specific distribution of the 195- 
kD molecule. 
An interesting feature of AEU-staining is that sometimes 
reaction products appear as punctate spots located at the cell 
periphery (Fig. 3 c). To determine whether such a staining 
pattern may be due to desmosomes, we stained (methanol- 
permealized) cultured human epidermal colonies with a rab- 
bit antiserum against desmosomal proteins (kindly provided 
by Dr. Malcolm Steinberg of Princeton University; Fig. 6 c). 
A  staining pattern clearly different from that produced by 
AEll was obtained. While AEll stains all upper, squamous 
cells in a more or less uniform fashion (Figs. 5 and 6 a) with 
occasional microvilli-like surface extensions (Fig. 6 b), anti- 
desmosome antibody stains intercellular punctates, some of 
which form rows presumably existing between the super- 
ficial and the underlying cells (Fig. 6 c). Thus, although we 
cannot rule out the possibility that some of the 195-kD pro- 
tein may be present in desmosomes, it is certainly not limited 
to such sites. 
The 195-kD Protein is a Submembranous Protein 
To determine whether the 195-kD molecule is exposed on the 
cell surface, we stained living, cultured human epidermal 
keratinocytes with AEll. With the exception of weak, punc- 
tam staining in the cell-cell  junctional zone of some ceils, no 
specific staining was observed (data not shown). In another 
experiment, we found that the 195-kD antigen remains intact 
in trypsinized human epidermal cells that are viable (Fig. 7, 
lane  1),  but  it  can  be  readily  degraded  by  trypsin  in 
detergent-permeabilized cells  (Fig.  7,  lane  4).  Taken to- 
gether, these results indicate that the 195-kD antigen is pri- 
marily an intraceUular protein that becomes susceptible to 
AEll  staining (Fig.  5) and to proteolytic degradation only 
when the cellular membrane is disrupted. 
The 195-kD Protein Is Not an Integral Membrane 
Protein, and Exists in Two.Separate (Tris-soluble 
vs. -insoluble) Pools 
To investigate the solubility property of the 195-kD protein, 
we serially extracted cultured human epidermal keratino- 
cytes with Tris buffer (to release the "cytosolic" proteins), 
Triton X-100 ("membrane" proteins), and finally SDS ("in- 
soluble" proteins). When these three fractions were heated 
in SDS sample buffer containing a reducing agent and then 
analyzed by immunoblotting using AEll, the 195-kD protein 
was detected in both the cytosolic and insoluble fractions, but 
not in the membrane fraction (Fig. 8, a and a'). That the Tris- 
extraction step is complete is established by the observation 
that  the  195-kD  antigen  is  not  detectable  in  the  Triton- 
fraction even in grossly overloaded (>5 times) gels. These 
results strongly suggest that the 195-kD protein is not an inte- 
gral  membrane protein,  and that it exists in two separate 
pools as defined by their solubility in Tris-buffer. 
The mechanism by  which the  195-kD  protein assumes 
different solubility characteristics (Tris-soluble vs. -insolu- 
ble)  was  investigated.  Fig.  8  b  shows  the  SDS  gel  elec- 
Figure 6.  Comparison of the AEll and antidesmosome antibody 
staining patterns of cultured human epidermal keratinocytes. Kera- 
tinocytes were MEOH-treated and stained with (a and b) AEll, or 
(c) antidesmosome. Note in a that the staining is somewhat concen- 
trated at the cell periphery. Occasionally, the staining appears to be 
associated with microvilli (b), suggesting a close proximity of the 
AEll-antigen and cell surface structures. (c) Antidesmosome stain- 
ing. Note strong, punctate staining at cell-cell junctions; many of 
the stained spots form "streaks" connecting the superficial squa- 
mous cells and the underlying cells. Bar, 20 ~tm. 
trophoretic patterns of the three keratinocyte fractions that 
have been heated in SDS sample buffer without a reducing 
agent. While the overall protein patterns of the nonreduced 
samples (Fig. 8 b) are very similar to those of the reduced 
samples (Fig. 8 a), individual bands of the former tend to be 
strong AEll staining of many superficial, squamous cells. (b) Phase contrast picture of the same field as in a. (c) Side view. A confluent 
sheet of epidermal keratinocytes was detached from the dish with dispase, embedded in OCT medium, sectioned vertically, and stained 
with AEll. Arrows denote the bottom of the colony originally in contact with the plastic surface. Note the preferential AEll-staining of 
superficial squamous cells. (d) Phase contrast picture of the same field as c. Bar, 20 ~tm, 
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of the 195-kD antigen, l'o- 
tal proteins were extracted 
from  cultured human  epi- 
dermal  keratinocytes after 
various treatments, and ana- 
lyzed with AEll by immu- 
noblotting.  Lane  1,  intact 
keratinocytes  isolated  by 
scraping with a rubber po- 
liceman. Lane 2, viable ke- 
ratinocytes isolated by tryp- 
sinization.  The  cells  were 
then incubated as a single- 
cell  suspension in  serum- 
free medium at 37°C for 25 
min to serve as a control. 
Lane 3, same as in lane 2, 
but cells were treated with 
0.1% Triton X-100 before  the 
3-/°C incubation  starts. Lane 
4, same as in lane 3, except 
that the Triton-treated cells 
were digested with 0.125% 
trypsin in serum-free medi- 
urn during incubation. Note 
that the  195-kD protein is 
present in lanes 1-3, but not 
in lane 4. 
more diffuse. This diffusion  is particularly pronounced in the 
region of the gel containing the 56-, 58-, and 59-kD keratins 
(Fig. 8 b, vertical bar next to lane 6).  Immunoblotting re- 
vealed a small but reproducible difference in the mobilities 
of the soluble and the insoluble 195-kD band, with the in- 
soluble species displaying a slightly higher apparent molecu- 
lar weight. Since this difference in electrophoretic mobility 
can be abolished by treating the samples with a  reducing 
agent (Fig. 8 a'), it is probably related to the presence of a 
disulfide bond(s) in the nonreduced 195-kD molecule. In a 
preliminary experiment designed to  test whether this  di- 
sulfide bond may be directly responsible for the insolubility 
of a subpopulation of the 195-kD antigen, we extracted the 
Tris-insoluble fraction of cultured human epidermal kera- 
tinocytes with 50 mM Tris/HCl (pH 7.4) containing 5 % 13- 
mercaptoethanol. Immtmoblotting results indicate that the 
insoluble fraction was not released.  This negative finding 
does not exclude the possibility that disulfide  bond formation 
may play a role in the insolubilization of the 195-kD antigen, 
however, since it is possible that disulfide bonds buried in the 
interior, hydrophobic domain of a protein may be protected 
from reducing agents unless the protein is first unfolded by 
a denaturant. 
Solubility of 195-kD Protein in "Basal" 
vs.  "Differentiated" Cells 
To determine whether the solubility of the 195-kD molecule 
may be differentiation-related, we subjected confluent hu- 
man epidermal cultures to an overnight treatment with a 
medium containing a low concentration of calcium (7). This 
allowed us to dislodge the suprabasal cell layers, leaving be- 
hind a monolayer highly enriched in undifferentiated, basal 
cells. The  195-kD molecules of such a basal culture were 
found to be highly soluble (Fig. 9, lanes 1 and 2), as com- 
pared with the control culture (Fig. 9, lanes 3 and 4). 
Discussion 
Using the AEll monoclonal antibody, we have identified and 
characterized a  195-kD antigen in human epidermal kera- 
tinocytes. This  antigen has  a  tissue  distribution different 
from that of several other previously studied molecules of  the 
same molecular weight range including myosin heavy chain 
(200 kD [13]), a 210-kD microtubule-associated protein (4), 
fibronectin (220 kD [19, 34]), alpha-spectrin (240 kD [14]), 
and ankyrin (200 kD [2]).  It is also immunologically (Fig. 
4) and electrophoretically distinguishable from desmoplakin 
I (230 kD) and H (205 kD) which are structural proteins of 
the desmosomes (6,  11). 
The AEll-reactive 195-kD protein exists in two different 
pools in keratinocytes: a Tris-soluble and a Tris-insoluble one. 
The insoluble  195-kD protein is also distinguishable from 
the soluble form in that the former exhibits a slightly higher 
apparent molecular weight and is most likely disulfide-cross- 
linked. There are two possible mechanisms by which this 
disulfide bond can potentially affect the solubility of a pro- 
tein.  An  intramolecular bond  may "fix" the protein  in  a 
configuration that is less soluble. Preliminary experiments 
indicate that such a bond, if it exists, may not be readily ac- 
cessible to a reducing agent without first denaturing the pro- 
tein. Alternatively, an intermolecular bond may cross-link 
the protein, which in itself may be quite soluble, to another 
highly insoluble molecule. The latter possibility seems less 
likely, however, since the difference in the apparent molecu- 
lar weights of the insoluble vs. soluble forms of the 195-kD 
antigen is only 1-2 kD, which would be surprisingly small 
to account for a molecule that can cause a significant shift 
in the solubility of a protein as large as  195-kD. 
An obvious question with regard to the two pools of 195- 
kD antigen concerns their possible precursor-product rela- 
tionship. Because our AEll antibody does not work well in 
immunoprecipitation, we have not yet been able to perform 
the  definitive pulse-chase  experiment.  However,  existing 
evidence strongly suggests that the soluble pool may repre- 
sent a precursor of the insoluble pool, and that the conver- 
sion from soluble to insoluble is  related to keratinocyte- 
differentiation. First, human epidermal keratinocyte cultures 
enriched  in  relatively  undifferentiated cells  contain  pre- 
dominantly  the  soluble  195-kD  protein,  whereas  highly 
differentiated cultures and in vivo epidermis contain mainly 
the insoluble form (Fig. 9). Second, immunohistochemical 
staining  of  frozen  sections  of normal  human  epidermis 
showed that the AEll-staining of the lower layers can be 
largely eliminated by prolonged washing of the tissue sec- 
tions with an aqueous buffer. In contrast, cells of the upper 
layers exhibit strong cell-peripheral staining, in addition to 
some soluble, cytoplasmic AEll-reactivity. Significantly, this 
cell-peripheral staining of the differentiated cells is resistant 
to Tris-extraction and therefore probably corresponds to the 
Tris-insoluble pool of the 195-kD antigen. 
Although it is quite clear that the expression of the 195-kD 
protein increases as the keratinocytes become more differen- 
tiated,  immunohistochemical-staining data  suggest that  it 
may already be present in small quantities (both cytoplasmic 
and peripheral) in basal cells (Figs.  3 a and 4 b and c). The 
The Journal of Cell Biology, Volume 103, 1986  46 Figure 8. Solubility and electrophoretic mobility of the 195-kD protein. Human epidermal keratinocytes were serially extracted with equal 
volumes of 50 mM Tris-HC1 (pH 7.4) (lanes 1 and 4), 50 mM Tris plus 0.1% Triton X-100 (lanes 2 and 5), and 50 mM "Iris plus 9 M 
urea (lanes 3 and 6). Equal proportions  of the samples were then treated with SDS sample buffer with (a and a') or without (b and b~ 
1% B-mercaptoethanol, and analyzed by 12.5% polyacrylamide gel electrophoresis (acrylamide/bisacrylamide  ratio:  120:1). (a and b) Fast 
green staining; (a' and b') AEll blotting patterns.  Lanes 4-6 are slightly overloaded repeats of lanes 1-3; they better illustrate the small 
difference in the mobilities of the soluble vs. insoluble forms of the 195-kD band.  Note that the AEU-reactive 195-kD antigen is present 
in '~1:2 ratio in the Tris- vs. urea-fraction, but is not detectable in the Triton-fraction. Also note that under the gel electrophoresis conditions 
of b the urea-soluble  195-kD protein migrates slightly behind the Tris-soluble counterpart.  The vertical bar next to lane 6 of b denotes 
the 56-59 kD keratin region. 
observation that the  195-kD molecule is present in a  Tris- 
soluble form in a low-calcium-induced monolayer culture is 
also consistent with its being present in basal cells (Fig. 9). 
This  latter  observation  must be interpreted  with  caution, 
however, because monolayers prepared by the low-calcium 
medium most likely contain some differentiated cells in addi- 
tion to the undifferentiated,  true basal cells (32). 
Based on the observations that the  195-kD antigen is not 
present in the Triton-fraction, and that it is protected from 
trypsin digestion in intact cells, we conclude that the antigen 
Figure 9.  Solubility of the  195 kD pro- 
tein in "basal" keratinocytes (lanes 1 and 
2) and in intact, stratified colonies (lanes 
3 and 4). Lanes 1 and 3 are Tris-soluble, 
and lanes 2 and 4 are urea-soluble pro- 
teins.  Human epidermal  keratinocytes 
were treated  overnight with a medium 
containing a low calcium concentration 
(see Materials and Methods) in order to 
loosen the suprabasal cell layers, leaving 
a monolayer highly enriched in undiffer- 
entiated, basal cells (lanes I and 2). Im- 
munoblotting  of equal  proportions  of 
samples  with  AEU  (similar  to Fig.  8) 
shows that >70% of the 195-kD protein 
is soluble in basal keratinocytes (lanes 1 
and 2), but only <30% is soluble in in- 
tact, stratified colonies (lanes 3 and 4). 
cannot be an integral membrane protein, and must be located 
intraceUularly. These observations, coupled with the periph- 
eral AEll-staining of the upper, differentiated cells, suggest 
that the insoluble form of the  195-kD antigen is located in 
the submembranous zone. The precise immunolocalization 
of the antigen at the electron microscopic level has not yet 
been achieved, because none of the four anti-195-kD antibod- 
ies (one conventional and three monoclonals) that we have 
tested so far worked satisfactorily on fixed tissues (Warhol, 
M.,  M.  Simon, and A.  Ma,  unpublished observations). 
Recently, Simon and Green described several membrane- 
associated proteins that  are expressed late in  keratinocyte 
differentiation, and showed that these proteins are substrates 
for transglutaminase-mediated cross-linking  (21, 22).  Our 
195-kD antigen appears to be identical to one of these pro- 
teins in its molecular weight (195-kD), charge (pI 5.4), im- 
munofluorescent  staining  pattern  in  epidermis,  and  im- 
munoreactivity.  2 The solubility of this previously described 
195-kD molecule seems to differ from ours, however, in that 
it was found only in the particulate membrane fraction dur- 
ing  sucrose-density-flotation,  whereas  in  our experiments 
a significant proportion of the 195-kD antigen is detected in 
a  soluble  pool  (Figs.  8  and  9).  The  reason  for this  dis- 
2. Two-dimensional immunoblotting experiments have established that the 
same  195-kD  protein was recognized by both our AEI1  antibody and a 
mouse polyclonal antiserum previously made by  Simon and Green (21) 
against a 195-kD transglutarninase substmte (Simon, M., and A. Ma, data 
not shown). 
Ma and Sun 195-kD Protein  and Keratinocyte  Differentiation  47 crepancy is not clear, although it could be related to different 
methods  of detection.  Immunoblotting  with a  monoclonal 
antibody  as described here may be more sensitive an assay 
than surveying the protein spots by two-dimensional gel elec- 
trophoresis, as was used in the earlier study  (21, 22). If this 
interpretation  is correct, results accumulated to date may be 
incorporated into a unifying  scheme  in which the  195-kD 
protein may be first synthesized as a cytosolic component. 
In the submembranous zone, particularly  that of the differen- 
tiated cells, some of this protein may become disulfide-cross- 
linked, perhaps enzymaticaUy,  and become Tris-insoluble. 
Finally, this membrane-associated 195-kD molecule is cross- 
linked through  isopeptide-bonds,  either among themselves 
or  to  other  molecules  such  as  involucrin,  by  transglu- 
taminase which is known to be largely membrane-bound (8, 
22,  28),  and  becomes  covalently  incorporated  into  the 
cornified envelope. More experiments are needed to test the 
validity  and  to  elucidate  the  detailed  mechanisms  of this 
scheme. 
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